These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Plasma homocysteine and severity of thoracic aortic atherosclerosis. Tribouilloy CM; Peltier M; Iannetta Peltier MC; Trojette F; Andrejak M; Lesbre JP Chest; 2000 Dec; 118(6):1685-9. PubMed ID: 11115459 [TBL] [Abstract][Full Text] [Related]
3. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Verhoef P; Stampfer MJ; Buring JE; Gaziano JM; Allen RH; Stabler SP; Reynolds RD; Kok FJ; Hennekens CH; Willett WC Am J Epidemiol; 1996 May; 143(9):845-59. PubMed ID: 8610698 [TBL] [Abstract][Full Text] [Related]
4. Homocyst(e)ine metabolism in hemodialysis patients treated with vitamins B6, B12 and folate. Henning BF; Zidek W; Riezler R; Graefe U; Tepel M Res Exp Med (Berl); 2001 Mar; 200(3):155-68. PubMed ID: 11426667 [TBL] [Abstract][Full Text] [Related]
5. Patients with atherosclerotic vascular disease: how low should plasma homocyst(e)ine levels go? Spence JD Am J Cardiovasc Drugs; 2001; 1(2):85-9. PubMed ID: 14728038 [TBL] [Abstract][Full Text] [Related]
6. Can transthoracic echocardiography with subcostal view predict abdominal aortic atherosclerosis? Ahmed S; Rehan A; Ahmad I; Gardin JM; Nanda NC; Cohen GI Echocardiography; 2005 Oct; 22(9):736-42. PubMed ID: 16194167 [TBL] [Abstract][Full Text] [Related]
7. Fluid dynamics and atherosclerosis development in the human thoracic aorta: a transesophageal echocardiographic evaluation of protruding aortic plaque distribution and motion. Tenenbaum A; Motro M; Shapira I; Feinberg MS; Schwammenthal E; Pines A; Vered Z; Fisman EZ J Med; 2000; 31(1-2):63-76. PubMed ID: 10998756 [TBL] [Abstract][Full Text] [Related]
8. Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine. Ducloux D; Fournier V; Rebibou JM; Bresson-Vautrin C; Gibey R; Chalopin JM Clin Nephrol; 1998 Apr; 49(4):232-5. PubMed ID: 9582553 [TBL] [Abstract][Full Text] [Related]
9. Transesophageal echocardiographically detected atherosclerotic aortic plaque is a marker for coronary artery disease. Fazio GP; Redberg RF; Winslow T; Schiller NB J Am Coll Cardiol; 1993 Jan; 21(1):144-50. PubMed ID: 8417055 [TBL] [Abstract][Full Text] [Related]
10. Vitamin intake: a possible determinant of plasma homocyst(e)ine among middle-aged adults. Shimakawa T; Nieto FJ; Malinow MR; Chambless LE; Schreiner PJ; Szklo M Ann Epidemiol; 1997 May; 7(4):285-93. PubMed ID: 9177112 [TBL] [Abstract][Full Text] [Related]
11. Transesophageal echocardiography can be used to screen for ascending aortic atherosclerosis. Konstadt SN; Reich DL; Kahn R; Viggiani RF Anesth Analg; 1995 Aug; 81(2):225-8. PubMed ID: 7618706 [TBL] [Abstract][Full Text] [Related]
12. Elevated serum lipoprotein(a) level is an independent marker of severity of thoracic aortic atherosclerosis. Peltier M; Iannetta Peltier MC; Sarano ME; Lesbre JP; Colas JL; Tribouilloy CM Chest; 2002 May; 121(5):1589-94. PubMed ID: 12006448 [TBL] [Abstract][Full Text] [Related]
13. Influence of folic acid, pyridoxal phosphate and cobalamin on plasma homocyst(e)ine levels and the susceptibility of low-density lipoprotein to ex-vivo oxidation. Weiss N; Feussner A; Hailer S; Spengel FA; Keller C; Wolfram G Eur J Med Res; 1999 Oct; 4(10):425-32. PubMed ID: 10527956 [TBL] [Abstract][Full Text] [Related]
14. Relation between the incidence, location, and extent of thoracic aortic atherosclerosis detected by transesophageal echocardiography and the extent of coronary artery disease by angiography. Gu X; He Y; Li Z; Kontos MC; Paulsen WH; Arrowood JA; Vetrovec GW; Nixon JV Am J Cardiol; 2011 Jan; 107(2):175-8. PubMed ID: 21129720 [TBL] [Abstract][Full Text] [Related]
16. Homocyst(e)ine: an important risk factor for atherosclerotic vascular disease. Duell PB; Malinow MR Curr Opin Lipidol; 1997 Feb; 8(1):28-34. PubMed ID: 9127708 [TBL] [Abstract][Full Text] [Related]
17. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease. Manns BJ; Burgess ED; Hyndman ME; Parsons HG; Schaefer JP; Scott-Douglas NW Am J Kidney Dis; 1999 Oct; 34(4):669-77. PubMed ID: 10516348 [TBL] [Abstract][Full Text] [Related]
18. Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial. Sesmilo G; Biller BM; Llevadot J; Hayden D; Hanson G; Rifai N; Klibanski A J Clin Endocrinol Metab; 2001 Apr; 86(4):1518-24. PubMed ID: 11297577 [TBL] [Abstract][Full Text] [Related]
19. What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 micromol/L. Hackam DG; Peterson JC; Spence JD Am J Hypertens; 2000 Jan; 13(1 Pt 1):105-10. PubMed ID: 10678280 [TBL] [Abstract][Full Text] [Related]
20. Atherosclerotic plaque detected by transesophageal echocardiography is an independent predictor for all-cause mortality. Heidari H; Ran H; Spinka G; Hengstenberg C; Binder T; Goliasch G; Schneider M Int J Cardiovasc Imaging; 2020 Aug; 36(8):1437-1443. PubMed ID: 32301042 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]